Santhera to share latest on commercial rollout of AGAMREE® and future strategic priorities at Capital Markets Day [Yahoo! Finance]
Catalyst Pharmaceuticals, Inc. (CPRX)
Last catalyst pharmaceuticals, inc. earnings: 3/16 05:26 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.catalystpharma.com
Company Research
Source: Yahoo! Finance
Company will discuss the commercial progress with the global roll-out of AGAMREE® for the treatment of Duchenne Muscular Dystropy (DMD). The Company will also outline plans for further market expansion and provide an update on its strategic direction beyond DMD. The Company continues to evaluate opportunities to expand its rare disease portfolio as part of its strategy to establish itself as a leading specialty pharmaceutical company. The CMD will feature presentations from Santhera's leadership team, including Dario Eklund, CEO; Dr Shabir Hasham, Chief Medical Officer; and Catherine Isted, Chief Financial Officer. Additionally, Prof. Luca Bello MD, PhD, Associate professor of neurology, and neuromuscular clinician at the ?University of Padova,
Read more
Impact Snapshot
Event Time:
CPRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CPRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CPRX alerts
High impacting Catalyst Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
CPRX
News
- Why a Clutch of Pharmaceutical and Biotech Stocks Escaped the Market's Swoon on Thursday [Yahoo! Finance]Yahoo! Finance
- What Makes Catalyst Pharmaceuticals (CPRX) an Investment Choice? [Yahoo! Finance]Yahoo! Finance
- Is Catalyst Pharmaceuticals, Inc. (CPRX) the Best Healthcare Stock For Long-Term Investment? [Yahoo! Finance]Yahoo! Finance
- We Think Catalyst Pharmaceuticals' (NASDAQ:CPRX) Robust Earnings Are Conservative [Yahoo! Finance]Yahoo! Finance
- Catalyst Pharmaceuticals to Participate in the Barclays 27th Annual Global Healthcare ConferenceGlobeNewswire
CPRX
Earnings
- 2/26/25 - Beat
CPRX
Sec Filings
- 3/7/25 - Form 4
- 3/6/25 - Form 144
- 3/5/25 - Form 4
- CPRX's page on the SEC website